The high-flow oxygen therapy equipment market share is expected to increase at a compound annual growth rate (CAGR) of 0.5% over the projected period, according to FMI’s estimate. In 2023, the sector is expected to be valued at US$ 1,494.8 million on the market.
It is anticipated that developments in device development and manufacturing would have a favourable impact on the market. The significant respiratory disorders’ high disease epidemiology is another driver driving the market.
The presence of seasoned medical assistive devices and a strong healthcare infrastructure in developed economies are driving market expansion. Producers stand to benefit from the increasing need for equipment tailored to individual patients, which is expected to drive growth in the high-flow oxygen therapy devices market.
The market is projected to be negatively affected by high costs, patient discomfort, and a shortage of trained healthcare personnel. In addition, numerous product recalls are expected to hinder the demand for high-flow oxygen therapy devices.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13794
Top Highlights from the FMI’s Analysis of the High-flow Oxygen Therapy Devices Market:
- The North America high-flow oxygen therapy devices industry is projected to attain a 29.8% value share in 2022.
- The United States high-flow oxygen therapy devices industry rules the North America market. The nation’s share in the market in 2022 was 28.7%.
- The Europe market gained a 16.6% value share in 2022.
- Germany has enjoyed a significant share of the high-flow oxygen therapy devices industry by attaining a 4.5% market share in 2022.
- The Japan high-flow oxygen therapy devices industry gained a market share of 7.8% in 2022.
- The Australian market is projected to register a CAGR of -0.7% from 2023 to 2033.
- The China high-flow oxygen therapy devices industry is expected to expand at 0.8% in the forecast period.
- The Indian market is anticipated to record a CAGR of -0.3% in the coming years.
- The United Kingdom’s high-flow oxygen therapy devices industry is projected to register a CAGR of -0.3% in the forthcoming years.
- Based on product, the heated humidifiers segment attained a 48.18% market share in 2022.
- Based on the application, acute respiratory failure is projected to acquire more than 90.46% in 2023.
- Under the end-user category, the ‘500 beds and above’ segment procured a market share of 51.5% in 2022.
Market Update: New Developments Taking Place in the Market
- Movair, previously called International Biophysics Corporation, released Luisa in October 2021. The latter is a complex ventilator for use in institutions, homes, and hospitals or for portable applications for invasive and non-invasive ventilation. To cater to the increasing demand for effective and safe ventilators, Luisa was introduced to the masses post the FDA’s Emergency Use Authorization.
- Noccarc Robotics Pvt. Ltd, which is IIT Kanpur incubate firm, introduced the Noccarc H210 in August 2020. This device was effective in treating COVID-19 patients.
- Goa Medical College bought 274 Carina ventilators in 2020. These ventilators were bought from Draeger in the initial months of the COVID-19 outbreak.
- Inspired Medical stated that its Inspired O2FLOTM gained FDA permission for emergency use in May 2020. The device can be deployed to treat patients suffering from hypoxemia or other serious respiratory symptoms.
Key Players:
- Draegerwerk AG & Co. KGaA
- Teleflex Medical GmBH
- Philips Respironics
- Vapotherm, Inc.
- ResMed
- Vyaire Medical, Inc.
- Fisher & Paykel Corporation Ltd.
- Armstrong Medical
- Flexicare Medical
- Hamilton Medical Inc.
- Intersurgical Inc.
- Inspired Medical
- WILAMed GmBH
- Besmed Health Business Corp
- Shenzhen Micomme Medical Technology Development Co. Ltd
- Shenyang RMS Medical Tech Co. Ltd.
- BMC Medical Co., Ltd.
Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-13794
Market by Categorization:
By Product:
- High-flow Nasal Cannulas
- High-flow Oxygen Masks
- Breathing Circuits
- Heated Humidifiers
- Accessories
By Application:
- Pneumonia
- Acute Respiratory Failure
By End User:
- Less than 100 Beds in Hospitals
- 100 to 250 Beds Hospitals
- 250 to 500 Beds Hospitals
- 500 Beds and Above Hospitals
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
